Pimasertib
- Generic Name
- Pimasertib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H15FIN3O3
- CAS Number
- 1236699-92-5
- Unique Ingredient Identifier
- 6ON9RK82AL
- Background
Pimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus).
- Associated Conditions
- -
- Associated Therapies
- -
Trial of Pimasertib in Hematological Malignancies
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2017-08-21
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 81
- Registration Number
- NCT00957580
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath